This stands in contrast to mouse models expressing MPN-derived mutations in JAK2 and CALR homologs at physiologic levels, which exhibit phenotypes resembling PV or ET, with little if any bone marrow fibrosis (75). This evidence concerns the gene JAK2 and myeloproliferative neoplasm.